Summary: Skye Bioscience Inc, a clinical-stage biopharmaceutical company, reported its second-quarter results, emphasizing the upcoming phase 2 trial of nimacimab, a treatment for obesity that will also explore the impact of weight loss on sleep quality using Beacon Biosignal’s … [Read more...]
Workplace Mistreatment Tied to Sleep Loss and Depression in Black Employees
Summary: Research from the Indiana University Kelley School of Business has found that workplace mistreatment disproportionately impacts Black employees, leading to significantly higher rates of sleep loss and depression compared to white employees. The study suggests that Black … [Read more...]
Can ED, Asthma Drugs Restore Sleep Deprivation Memory Loss?
Summary: Researchers from the University of Groningen have discovered that FDA-approved drugs for erectile dysfunction and asthma can restore social and spatial memories in sleep-deprived mice. The study, presented at the Federation of European Neuroscience Societies Forum 2024, … [Read more...]
Sleep Loss, Stress Take Toll on US High Schoolers, Study Shows
Summary: A new report by Challenge Success reveals a pattern of insufficient sleep and high stress among over 270,000 high school students surveyed over 14 years. Students who get more sleep reported better ability to cope with stress. The data highlights disparities, with … [Read more...]
Eli Lilly’s Weight Loss Drug Zepbound Cuts Sleep Apnea Severity
Summary: Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) reduced the severity of obstructive sleep apnea (OSA) by up to 63% in adults with obesity in two phase 3 trials. The drug improved sleep apnea symptoms in patients using and not using PAP therapy. Based … [Read more...]